We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Test Diagnoses Bacterial Meningitis Quickly and Accurately

By LabMedica International staff writers
Posted on 30 Apr 2025

Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. More...

Therefore, rapid diagnosis and treatment are critical. However, distinguishing bacterial meningitis from other similar conditions is often challenging for healthcare providers. Currently, it can take a considerable amount of time to diagnose meningitis, which delays the initiation of appropriate treatment. Until now, there have been no reliable diagnostic tests available that could quickly differentiate bacterial meningitis from other conditions. Researchers have now developed a new diagnostic test capable of quickly and accurately diagnosing bacterial meningitis by measuring the CRP protein in cerebrospinal fluid, a protein commonly tested in blood to detect bacterial infections.

Researchers at Amsterdam UMC (Amsterdam, Netherlands) found that the CRP protein in cerebrospinal fluid is a highly reliable indicator of bacterial meningitis. While CRP is often tested in blood to detect bacterial infections, its value in cerebrospinal fluid had not been extensively studied until now. After successful laboratory tests, the researchers demonstrated that the device used to measure CRP in blood is also sensitive enough to measure CRP in cerebrospinal fluid. Since June 2024, this new test has been incorporated into daily practice at Amsterdam UMC. In their latest, published in The Lancet Regional Health Europe, the researchers described how the test was introduced and assessed its effectiveness in a clinical setting.

The results showed that all patients diagnosed with bacterial meningitis had elevated CRP levels in their cerebrospinal fluid, whereas only a few patients without bacterial meningitis showed similar elevations. The test was also proven to be reliable in additional studies conducted with children and patients in Denmark. It is expected that more hospitals will begin to adopt this test, as it can be performed in laboratories with existing equipment. The cost of the test ranges from three to five euros, offering an affordable and accessible solution for diagnosing and treating bacterial meningitis more quickly.

"Any laboratory in which CRP is measured in blood can introduce this test for cerebrospinal fluid tomorrow. We could not have predicted in advance that a new diagnostic test would be used in patients within a year of its discovery," said last author and Amsterdam UMC neurologist, Matthijs Brouwer.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gastrointestinal Panel
Xpert® GI Panel
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical Abstract (Ziegler, AG., Rewers, M.J., Achenbach, P. et al. Diabetologia (2026). https://doi.org/10.1007/s00125-026-06841-z)

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.